In cancer, HVEM upregulation has been reported in various tumor cell lines and clinical tumor tissue, including breast and esophageal cancer, chronic lymphocytic leukemia, and melanoma [7,13,14,15]. This evidence concerns the gene TNFRSF14 and cancer.